MedTrace Logo

Impact of Endo-vac Therapy for Esophago-jejunal Anastomotic Leak

NCT07295236 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2025-12-29

No results posted yet for this study

Summary

The goal of this observational study is to assess the impact of endoscopic vacuum therapy in patients who underwent total gastrectomy due to gastric cancer and developed esophago-jejunal anastomotic leakage. The main outcomes to be investigated are the following:

Primary endpoint: mortality rate Secondary endpoints: morbidity rate, time from AL diagnosis to discharge, patients satisfactory rate.

Conditions

  • Esophagojejunal Anastomotic Leak

Sponsors & Collaborators

  • Ukrainian Society of Clinical Oncology

    lead OTHER

Principal Investigators

  • Oleksii Dobrzhanskyi, MD · National Cancer Institute (NCI)

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-12-01
Primary Completion
2030-12-01
Completion
2035-12-01

Countries

  • Ukraine

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07295236 on ClinicalTrials.gov